Highlights ClouDr Group Limited

Equities

9955

KYG2216H1011

Delayed Hong Kong S.E. Other stock markets 03:30:17 2024-05-23 am EDT			5-day change	1st Jan Change
3.04 ^HKD	-5.59%		-8.16%	-55.62%

Apr. 15	ClouDr Launches Digital Employee to Improve Online-to-Offline Operation Services	MT
Mar. 22	ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ClouDr Launches Digital Employee to Improve Online-to-Offline Operation Services	Apr. 15	MT
ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5%	Mar. 22	MT
ClouDr Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
ClouDr Group Limited Announces Launch of Proprietary Product, Hetangjin Dapagliflozin Tablets	Mar. 10	CI
ClouDr Group Limited Enters into A Non-Legally Binding Strategic Cooperation Agreement with China Resources Kunming Shenghuo Pharmaceutical Co., Ltd	Mar. 05	CI
ClouDr Buys Back Shares	Jan. 25	MT
ClouDr Group Trustee Buys 1.3 Million Shares Under Award Scheme	Jan. 17	MT
ClouDr Unit to Get 200 Million Yuan Capital Injection	Jan. 12	MT
ClouDr Buys Back Shares for Incentive Scheme	Jan. 11	MT
ClouDr Group Applies to Register Diabetes Digital Therapeutics in China	Jan. 03	MT
ClouDr Group Limited Completes the Application for Registration as A Medical Device in the People's Republic of China in Respect of ClouDT-01	Jan. 03	CI
ClouDr Group to Buy Up to HK$80 Million of Shares	Dec. 28	MT
ClouDr Signs Marketing Deal With Shanxi Jinbo Bio Pharmaceutical	Dec. 28	MT
ClouDr Group Limited Enters into a Non-Legally Binding Strategic Cooperation Agreement with Shanxi Jinbo Bio-Pharmaceutical Co., Ltd	Dec. 27	CI
ClouDr Group Signs Digital Marketing Agreement with Pharmaceutical Company	Nov. 29	MT
ClouDr Group Limited Announces New Efficacy of Ischelium on Brain Covidative Fund Approval	Nov. 15	CI
ClouDr Group Chairman/CEO Boosts Shareholding	23-10-31	MT
ClouDr Group to Partner with Hong Kong Magicure to Facilitate Cross-Border Access to Drugs in China	23-09-07	MT
ClouDr Group Limited Enters into A Non-Legally Binding Strategic Cooperation Agreement with Hong Kong Magicure Medical Co., Ltd	23-09-07	CI
ClouDr Group's H1 Loss Narrows	23-08-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ClouDr Group Limited

Equities

9955

KYG2216H1011

Highlights

Filters